Managing supply chain disruptions in pharmaceutical distribution: the roles of disruption orientation and mitigation strategies

Purpose

The present study investigates the impact of supply chain disruption orientation (SCDO) on four supply chain disruption (SCD) mitigation strategies: supply chain integration (SCI), supply chain agility (SCA), supply chain visibility (SCV) and supply chain redundancy (SCR). It also examines the impact of the four mitigation strategies on SCD. The impact of the latter on business performance (BP) is also explored.

Design/methodology/approach

This study employs an empirical approach through survey research methodology. It analyzes data collected from 304 managers from pharmaceutical distribution companies in Jordan. Appropriate validity and reliability tests were employed for the study constructs. Path analysis using AMOS software was performed to test the study hypotheses.

Findings

SCDO was found to positively affect all SCD mitigation strategies. Furthermore, among the four mitigation strategies examined, SCV exhibited the highest significant impact in reducing SCD, followed by SCA and then SCR. However, the results revealed that SCI did not significantly impact SCD. Additionally, SCD proved to be negatively and significantly related to BP.

Originality/value

The present study fills a gap in the literature regarding the management of SCDs in pharmaceutical supply chains (SCs) generally and SCs of pharmaceutical distribution companies specifically. It also addresses an under-investigated area in the literature concerning the role of SCDO in promoting the adoption of SCD mitigation strategies.